Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
Titel:
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
Auteur:
Kim, Dong-Wan Lee, Dae Ho Han, Ji-Youn Lee, Jongseok Cho, Byoung Chul Kang, Jin Hyoung Lee, Ki Hyeong Cho, Eun Kyung Kim, Jin-Soo Min, Young Joo Cho, Jae Yong An, Ho Jung Kim, Hoon-Gu Lee, Kyung Hee Kim, Bong-Seog Jang, In-Jin Yoon, Seonghae Han, OakPil Noh, Young Su Hong, Ka Young Park, Keunchil